Leukos Biotech, S.l.

Enantia, S.l.

Kern Pharma, S.l.

F.i.s. Fabbrica Italiana Sintetici S.p.a.

Montserrat Trilla Castaño

Nicolas Tesson

Elena Brasola

Alexander Christian Comely

Filippo Tomasi

Enrique Llaudet Carles

The present invention relates to solid compositions comprising cocrystals of cannabinoids, processes for their preparation, and their use as in therapy or in cosmetics or for the purification of cannabinoids. It also relates to cocrystals of cannabinoids.

Solid compositions of cocrystals of cannabinoids

A pharmaceutical composition comprising apomorphine (APO) in a solid crystalline form, wherein the solid crystalline form is an APO&#xb7;palmitic acid cocrystal solid particle crystalline form.

Apomorphine-palmitic acid cocrystal solid particle crystalline form

A cocrystal of (S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid and an amino acid, in particular L-valine or L-2-aminobutyric acid, their preparation processes, as well as the preparation process of Ambrisentan or Darusentan using any of the cocrystals of the invention.

Preparation process of carboxylic acid derivatives and intermediates thereof

Growing community of inventors

Barcelona, Spain

Montserrat Trilla Castaño